文献速递食管与纵隔外科

食管切除术后30天再入院的全国性分析:原因、费用与危险因素

Nationwide Analysis of 30-Day Readmissions After Esophagectomy: Causes, Costs, and Risk Factors.
PubMed 文献 · Ann Thorac Surg · 2019-09-26

该研究基于2010至2014年全国再入院数据库,分析13,282例食管切除术患者,30天再入院率为19.4%,最常见原因为肺部(20.6%)和胃肠道并发症(20%)。再入院中位费用为9,660美元,肺部并发症占总费用负担的25.8%。独立危险因素包括围手术期输血、出院至护理机构、高疾病严重度、慢性肾衰竭和药物滥用。

要点

  • 食管切除术后30天再入院率近1/5,肺部并发症最常见且费用负担最大。
  • 围手术期输血、出院至护理机构、慢性肾衰竭等为独立危险因素。
  • 针对肺部并发症的干预可能降低再入院率和医疗费用。

核心结论

  • 近1/5食管切除术患者在出院后30天内再入院,中位费用9,660美元。
  • 肺部并发症导致再入院数量最多且总费用负担最大。

研究设计与样本

  • 回顾性队列研究,使用2010至2014年全国再入院数据库,纳入13,282例食管切除术患者。
  • 采用多变量逻辑回归分析再入院的医院、操作和患者层面危险因素。

主要发现

  • 30天再入院率为19.4%,最常见指征为肺部并发症(20.6%)和胃肠道并发症(20%)。
  • 再入院中位费用为9,660美元(四分位距5,392至20,447美元),肺部并发症占再入院总费用的25.8%。

临床怎么用

  • 对食管切除术患者应重点关注肺部并发症的预防和管理以降低再入院风险。
  • 识别具有围手术期输血、出院至护理机构、慢性肾衰竭等高危因素的患者,加强出院后随访。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Postsurgical readmissions are an increasingly scrutinized marker of health care quality. We sought to estimate the rate, risk factors, causes, and costs associated with readmissions after esophagectomy in a large, nationally representative cohort. METHODS: We studied patients from the Nationwide Readmissions Database undergoing esophagectomy from 2010 to 2014. Data were collected on the prevalence and indications for readmission within 30 days as well as the hospital-, procedure-, and patient-level risk factors as determined by multivariable logistic regression. RESULTS: Among 13,282 cases, the rate of 30-day readmission was 19.4%, with the most common indications for readmission being pulmonary (20.6%) and gastrointestinal complications (20%). Median cost of readmission was $9660 (interquartile range, $5392 to $20,447), and pulmonary complications accounted for the greatest total cost burden at 25.8% of all readmission-related costs. Independent risk factors for readmission on multivariable analysis included perioperative blood transfusion (adjusted odds ratio [AOR] 1.33; 95% confidence interval [CI], 1.08 to 1.65; P = .008), discharge to a nursing facility (AOR 1.83; 95% CI, 1.41 to 2.39; P < .001), high illness severity based on All Patients Refined Diagnosis-Related Groups scoring (AOR 1.49; 95% CI, 1.21 to 1.84; P < .001), chronic renal failure (AOR 1.61; 95% CI, 1.13 to 2.29; P = .009), and comorbid drug abuse (AOR 2.19; 95% CI, 1.08 to 4.41; P = .029). CONCLUSIONS: Nearly 1 in 5 patients undergoing esophagectomy are readmitted within 30 days of discharge, at a median cost of $9660 per readmission. Pulmonary complications account for the greatest number of readmissions and the greatest total cost burden. Targeting the causes of readmission, especially pulmonary causes, may help significantly reduce the total morbidity and health care costs associated with esophagectomy.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Goel NJ, Iyengar A, Kelly JJ, et al. Nationwide Analysis of 30-Day Readmissions After Esophagectomy: Causes, Costs, and Risk Factors. Ann Thorac Surg. 2019. PMID: 31563491. doi:10.1016/j.athoracsur.2019.08.035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。